Insights Into Recent Insider Trades on Healthcare Stocks Unveiling Recent Insider Trades on Promising Healthcare Stocks

Written By Michael Gary Scott



Although the closing bell rang higher for U.S. stocks on Wednesday, whispers abound of some intriguing insider trades.


When insiders dive into the market pool, it’s either a lifeguard-certified belief in the company’s future or a signal that the lifeguard blew his whistle on a bargain stock. Either way, the tide whispers of an opportunity, beckoning to float along with the insiders. However, one must understand that insider trades are akin to the fragrance of a cup of coffee – it can smell invigorating but doesn’t replace the actual taste test.


Behold, a glimpse into recent insider maneuvers. For further trawling, cast a glance at Benzinga’s insider transactions platform.


SunOpta


  • The Scene: SunOpta Inc. STKL CEO Brian W Kocher ventured into 38,000 shares at an average price of
    $6.65, totaling approximately $252,757.
  • The Plot Thickens: On Feb. 28, SunOpta displayed sunny quarterly results.
  • What’s SunOpta’s Game: SunOpta Inc., a Canadian entity, specializes in a healthy smorgasbord of products.




89bio


  • The Scene: 89bio, Inc. ETNB Director Rajeev Shah embraced a total of
    1,350,000 shares at an average price of $15.35, whisking away a staggering $20.72 million.
  • The Plot Thickens: On Feb. 29, 89bio published a quarterly loss slightly wider than anticipated.
  • What’s 89bio’s Game: 89bio Inc, a U.S. player, delves into clinical-stage biopharmaceuticals, dancing specifically
    to the beat of treating liver and cardio-metabolic maladies.


IonQ


  • The Scene: IonQ, Inc. IONQ Director Harry L. You added a slice of 115,000 shares at an average price of $9.28, with a monetary feast totaling around $1.07 million.
  • The Plot Thickens: On Feb. 28, IonQ excited investors with second-quarter revenues of $6.11 million, trumping the street’s whispers of $5.76 million.
  • What’s IonQ’s Game: IonQ Inc whistles the melody of quantum computing sales, offering various computer capacities melodically orchestrated and busy composing the future of galactic computational capabilities.
See also  Examining the Potential of Intel StockExamining the Potential of Intel Stock


 


Check This Out: Jim Cramer says, ‘This REIT Is ‘A Little Too Dicey’; As For Marathon Digital, ‘Own The Pure’